Open-Angle Glaucoma (OAG) Market Poised to Hit $8.36 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Open-Angle Glaucoma (OAG) Market Size Growth Forecast: What to Expect by 2025?
The market encompassing open-angle glaucoma treatments has exhibited robust expansion across recent years, projected to see its valuation ascend from $6.13 billion in 2024 to $6.53 billion the following year, reflecting a steady compound annual growth rate of 6.5%. This upward trajectory during the past timeframe stems from several factors: a greater incidence of glaucoma within aging demographics, heightened public consciousness regarding the importance of early identification of ocular conditions, escalating spending on healare services, the implementation of governmental programs aimed at supporting vision care, and the worldwide proliferation of ophthalmic medical practices.

How Will the Open-Angle Glaucoma (OAG) Market Size Evolve and Grow by 2029?
The market segment dedicated to open-angle glaucoma is projected to experience considerable expansion over the coming years, achieving a valuation of $8.36 billion by 2029, underpinned by a compound annual growth rate (CAGR) of 6.4%. This upward trajectory throughout the projection timeframe stems from several key factors, notably the heightened need for therapeutic regimens combining multiple agents, a greater emphasis on tailoring medical approaches to individual patients, enhancements in the coverage provided for glaucoma interventions, the escalating incidence of eye ailments linked to modern lifestyles, and a growing preference for diagnostic techniques that do not require invasive procedures. Regarding dominant patterns expected during this period, one can observe the accelerating uptake of artificial intelligence within glaucoma diagnosis, a movement favoring surgical operations for glaucoma to be conducted in ambulatory settings, the expanding utilization of implants designed for sustained drug release in glaucoma care, heightened incorporation of wearable devices for monitoring internal eye pressure, and a strengthened commitment to environmentally conscious practices in the creation of ophthalmic medical apparatus.

View the full report here:
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

What Drivers Are Propelling the Growth of Open-Angle Glaucoma (OAG) Market Forward?
Increased recognition concerning visual ailments is anticipated to be a significant catalyst for the expansion of the open-angle glaucoma (OAG) market moving ahead.These afflictions, which involve medical issues affecting the eyes' physical makeup, operation, or sight capabilities, span a spectrum from mild discomforts like dryness to severe pathologies such as macular degeneration and glaucoma.Factors contributing to their increasing frequency include demographic shifts towards older populations, extended periods spent viewing digital screens, a rise in diabetes diagnoses, environmental contamination, and lifestyle choices detrimental to ocular wellness.Given that OAG stands as a primary contributor to vision loss, particularly among the elderly, the imperative for regular ophthalmic check-ups, timely identification, and timely intervention to prevent permanent sight impairment becomes paramount.As an illustration, data from the Royal National Institute of Blind People (RNIB) in the UK indicated that eye care outpatient visits surpassed eight million during the 2021/22 period, positioning it as the most heavily utilized service area, as reported in October 2023; furthermore, the current population experiencing vision impairment, already exceeding two million, is forecasted to double, reaching over four million by the year 2050, thereby solidifying the link between rising public awareness of eye diseases and the subsequent momentum in the OAG market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

Which Emerging Trends Are Transforming the Open-Angle Glaucoma (OAG) Market in 2025?
Key players within the open-angle glaucoma (OAG) landscape are focusing their efforts on pioneering novel approaches, notably minimally invasive glaucoma devices (MIGDs), to present sophisticated yet less intrusive options for managing primary open-angle glaucoma, thereby lessening the need for established therapies. MIGDs encompass various implantable devices and surgical procedures engineered to decrease intraocular pressure (IOP) in glaucoma sufferers via diminutive incisions with minimal disturbance to eye structures. To illustrate, iSTAR Medical, a medical technology firm headquartered in Belgium, introduced MINIject in the Netherlands in December of 2023; this bio-integrating therapy for primary open-angle glaucoma incorporates a distinct porous STAR substance intended to facilitate fluid drainage and subsequently lower IOP, positioning MINIject as a pivotal advancement in glaucoma treatment by offering a safer and superior management method to combat this primary driver of irreversible vision loss, moving away from customary interventions.

What Are the Key Segments in the Open-Angle Glaucoma (OAG) Market?
The open-angle glaucoma (oag)market covered in this report is segmented -

1) By Disease Type: Open Angle Glaucoma; Angle Closure Glaucoma; Other Disease Type
2) By Drug Class: Prostaglandin Analog; Beta Blockers; Adrenergic Agonist; Carbonic Anhydrase Inhibitors; Others Drug Class
3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG); Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma; Chronic Angle-Closure Glaucoma
3) By Other Disease Type: Normal-Tension Glaucoma; Congenital Glaucoma; Secondary Glaucoma

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Who Are the Key Players Shaping the Open-Angle Glaucoma (OAG) Market's Competitive Landscape?
Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

What Geographic Markets Are Powering Growth in the Open-Angle Glaucoma (OAG) Market?
North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.